[3P-1] Poster Presentation

1. Molecular - l. Others

[3P-330] Candidate therapeutic compounds selection rule for the xeroderma pigmentosum complementation group D mutant (R683W) as determined by in silico drug repurposing screening

○Aki Sugano^1,2,4, Mika Ohta^2,3, Satoshi Tateishi⁵, Yoshimasa Maniwa², Yutaka Takaoka^2,3,4 (1. CCTR, Toyama Univ. Hosp., 2. Dept. of Med. Syst., Kobe Univ. Grad. Sch. of Med., 3. Dept. of Comput. Drug Design and Math. Med., Grad. Sch. of Med. and Pharma. Sci., Toyama Univ., 4. Center for DS and AI Res. Promot., Toyama Univ. Hosp., 5. Dept. of Cell Maintenance, IMEG Kumamoto Univ.)

Password required to view

Log in

or